Positively Aware Emtriva

Emtriva and Epivir

emtricitabine FTC (NRTI) and lamivudine 3TC (NRTI)

Each is DHHS recommended as a component of initial regimen for most people
Nucleoside "Nuke"

Standard Dose

One Emtriva capsule once daily, with or without food, for adults and children regardless of age. One 300 mg Epivir tablet once daily (or one 150 mg tablet twice daily), with or without food. Emtriva and Epivir for children is dosed based on body weight; see the package insert. Epivir can be used by children at least 3 months of age. Emtriva is also available as an oral solution (10 mg/mL) (cotton candy flavored) for children and adults who cannot swallow the capsules. The dosing for the oral solution is as follows: 3 mg/kg for children 0–3 months, 6 mg/kg for children aged 3 months to 17 years, and 10 mg/kg for adults who are not able to swallow the capsules. Liquid dose is up to a maximum of 240 mg (24 mL) daily; the 200 mg capsule equals 240 mg solution. Emtriva oral solution should be kept in the refrigerator. If kept at room temperature, the oral solution should be used within three months. Emtriva can be substituted for Epivir. See package inserts for guidance on dosing in the setting of kidney impairment. Emtriva and Epivir must be taken in combination with another antiretroviral(s) from a different drug class.

Take missed dose as soon as possible, unless it is closer to the time of your next dose. Do not double up on your next dose.
  • See package insert for more complete information on potential side effects and interactions.
  • Generic is available.

Manufacturer

Gilead Sciences, Inc.
gilead.com
(800) GILEAD-5 (445–3235)

ViiV Healthcare
viivhealthcare.com
(877) 844-8872

AWP

Emtriva
200 mg, 30 capsules:
$643.82/month
generic: $579.37/month

Epivir
150 mg, 60 tablets:
$498.89/month
generic lamivudine 150 mg, 60 tablets:
$429.66/month
Epivir 300 mg, 30 tablets:
$498.89/month
generic lamivudine 300 mg, 30 tablets:
$429.66/month

Potential Side Effects and Toxicity

Potential Drug Interactions

More Information

Doctor Comments

Activist Comments